Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Robert P McMahonRobert R Conley

Abstract

To study the factor structure of symptoms in patients with treatment resistant schizophrenia and whether it is altered by treatment, we analyzed ratings on the Brief Psychiatric Rating Scale (BPRS) from two independent groups of patients with treatment resistant schizophrenia. With confirmatory factor analysis of pre-clozapine BPRS scores in 1074 patients in an administrative data base, the Clozapine Authorization and Monitoring Program (CAMP), we assessed the fit of published factor models and developed a better-fitting model. Model fit was validated in an independent group of 197 research unit participants. Stability of model fit six months post-clozapine was assessed in 834 CAMP patients. A new 4-factor model (negative symptoms, reality distortion, disorganization, and anxiety/depression) had better fit in both data sets than two commonly used factor models, and also fit better post-clozapine. We recommend these four factor scores as clinical trial outcomes in patients with treatment resistant schizophrenia.

Citations

Nov 3, 2005·Psychological Assessment·Alan Shafer
Aug 20, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·James A WaltzElliot A Stein
Jul 2, 2008·Schizophrenia Bulletin·James M GoldErin A Heerey
Aug 28, 2007·The Psychiatric Clinics of North America·Helio Elkis
May 25, 2016·The Psychiatric Clinics of North America·Helio Elkis, Peter F Buckley
Aug 31, 2014·Psychiatry Research·David C CiceroJohn G Kerns
Nov 22, 2011·Journal of Affective Disorders·Irene M LakoK Taxis
Jun 18, 2005·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Tânia Maria AlvesHélio Elkis
May 28, 2019·Brain Imaging and Behavior·Krista M WisnerL Elliot Hong
Oct 3, 2018·Cognitive, Affective & Behavioral Neuroscience·D HernausJ A Waltz
Dec 25, 2007·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Helio Elkis, Herbert Y Meltzer
Nov 14, 2018·Translational Psychiatry·Anya SavranskyL Elliot Hong
Jan 1, 2020·Computational Psychiatry·James A WaltzJames M Gold

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina
Tânia Maria AlvesHélio Elkis
European Archives of Psychiatry and Clinical Neuroscience
L LykourasC Stefanis
© 2022 Meta ULC. All rights reserved